New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
INVO Bioscience, Inc.
INVO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4M

Medical - Devices

Next Earning date - 11 Nov 2024

4M

Medical - Devices

Next Earning date - 11 Nov 2024

1.00USD
Shape0.36 ( 55.76%)
Market Open
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

4757%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

71%

Quote Panel

Shape
Updated October 14, 2024
1W 54.65 % 1M 49.64 % 3M 28.26 % 1Y 60.99 %

Key Metrics

Shape
  • Market Cap

    3.91M


  • Shares Outstanding

    3.91M


  • Share in Float

    3.88M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    1.002


  • Average Volume

    180412


  • Beta

    1.436


  • Range

    0.5-3.5


  • Industry

    Medical - Devices


  • Website

    https://www.invobio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.45x

P/S Ratio

1.76x

P/B Ratio

2.1

Debt/Equity

-122.8%

Net Margin

$0.7

EPS

How INVO compares to sector?

P/E Ratio

Relative Strength

Shape

INVO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$29M

Shape1458%

2025-Revenue

$0.20

Shape68%

2025-EPS

$29M

Shape-1611%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-4.20
vs -4.80

Q4.22

arrow
arrow

N/A

-4.55
vs -0.27

Q1.23

arrow
arrow

N/A

-4.00
vs -4.60

Q2.23

arrow
arrow

N/A

-3.06
vs -4.60

Q3.23

arrow
arrow

N/A

-0.70
vs -4.20

Q4.23

arrow
arrow

N/A

-1.27
vs -4.55

Q1.24

arrow
arrow

N/A

-0.42
vs -4.00

Q2.24

arrow
arrow

N/A

-0.62
vs -3.06

Q3.24

arrow
arrow

N/A

-0.09
vs -0.70

Q4.24

arrow
arrow

N/A

-0.06
vs -1.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+8%

235.3K  vs 218.9K

Q4.22

arrow
arrow

-91%

278.1K  vs 3M

Q1.23

arrow
arrow

+114%

348K  vs 162.6K

Q2.23

arrow
arrow

+116%

315.9K  vs 146.1K

Q3.23

arrow
arrow

+314%

974.9K  vs 235.3K

Q4.23

arrow
arrow

+397%

1.4M  vs 278.1K

Q1.24

arrow
arrow

+353%

1.6M  vs 348K

Q2.24

arrow
arrow

+481%

1.8M  vs 315.9K

Q3.24

arrow
arrow

+314%

4M  vs 974.9K

Q4.24

arrow
arrow

+248%

4.8M  vs 1.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-200%

-2.00
vs -0.83

Q4.22

arrow
arrow

+283%

2.83
vs -2.00

Q1.23

arrow
arrow

-3405%

-34.05
vs 2.83

Q2.23

arrow
arrow

+131%

1.31
vs -34.05

Q3.23

arrow
arrow

-335%

-3.35
vs 1.31

Q4.23

arrow
arrow

-223%

-2.23
vs -3.35

Q1.24

arrow
arrow

-15721%

-157.21
vs -2.23

Q2.24

arrow
arrow

-165%

-1.65
vs -157.21

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

18

18
vs 12

50%

Q1.22

arrow
arrow

20

20
vs 18

11%

Q2.22

arrow
arrow

17

17
vs 20

-15%

Q3.22

arrow
arrow

15

15
vs 17

-12%

Q4.22

arrow
arrow

21

21
vs 15

40%

Q1.23

arrow
arrow

21

21
vs 21

NA

Q2.23

arrow
arrow

17

17
vs 21

-19%

Q3.23

arrow
arrow

1

1
vs 17

-94%

Earnings Growth

Latest News